Figure 1From: Computational analyses of curcuminoid analogs against kinase domain of HER2 The rational workflow of this study, starting from in silico screening based on molecular docking and validated with cell line assays (SKBR3:a breast cancer cell line which over-expresses the HER2 gene product, MCF-7: a breast cancer cell line that absence of HER2 protein overexpression) and deep interaction study by molecular dynamic simulation. Back to article page